English

ENDOLOGIX INC /DE/

EDGAR

Filing (4) · filed 2020-08-14

119 filing records in this dataset, filed from 1996-08-14 to 2020-08-14. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

24.8 million USD

2020 Q2 · USD

Exact inputs and evidence

Revenue: 24841000 USD Source

Operating margin

-69.84%

2020 Q2 · %

Exact inputs and evidence

Operating Income: -17349000 USD Source
Revenue: 24841000 USD Source

Operating cash flow

-22 million USD

2020 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -31322000 USD Source
Operating Cash Flow: -9322000 USD Source

Free cash flow

-22 million USD

2020 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -31322000 USD Source
Operating Cash Flow: -9322000 USD Source
Capital Expenditure: 103000 USD Source
Capital Expenditure: 100000 USD Source

Cash and cash equivalents: 18.5 million USD 2020-06-30 Source
Exact value

18496000 USD
Long-term debt including current maturities: 193 million USD 2020-06-30 Source
Exact value

192687000 USD
Shares outstanding: 19.2 million shares 2020-06-30 Source
Exact value

19173845 shares

Reported share-count change

10.49% · 1.82 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

17352698 shares · 2019-06-30· Source
19173845 shares · 2020-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

125 million USD

2019-07-01 – 2020-06-30

Exact inputs and evidence

Revenue: 35775000 USD · 2019-07-01 – 2019-09-30 Source
Revenue: 35751000 USD · 2019-10-01 – 2019-12-31 Source
Revenue: 28510000 USD · 2020-01-01 – 2020-03-31 Source
Revenue: 24841000 USD · 2020-04-01 – 2020-06-30 Source

Net income

-59.8 million USD

2019-07-01 – 2020-06-30

Exact inputs and evidence

Net income: -7765000 USD · 2019-07-01 – 2019-09-30 Source
Net income: -7830000 USD · 2019-10-01 – 2019-12-31 Source
Net income: -18116000 USD · 2020-01-01 – 2020-03-31 Source
Net income: -26093000 USD · 2020-04-01 – 2020-06-30 Source

Operating cash flow

-40.4 million USD

2019-07-01 – 2020-06-30

Exact inputs and evidence

Operating cash flow: -24463000 USD · 2019-01-01 – 2019-09-30 Source
Operating cash flow: -20450000 USD · 2019-01-01 – 2019-06-30 Source
Operating cash flow: -29570000 USD · 2019-01-01 – 2019-12-31 Source
Operating cash flow: -24463000 USD · 2019-01-01 – 2019-09-30 Source
Operating cash flow: -9322000 USD · 2020-01-01 – 2020-03-31 Source
Operating cash flow: -31322000 USD · 2020-01-01 – 2020-06-30 Source
Operating cash flow: -9322000 USD · 2020-01-01 – 2020-03-31 Source

Capital expenditure

329 thousand USD

2019-07-01 – 2020-06-30

Exact inputs and evidence

Capital expenditure: 337000 USD · 2019-01-01 – 2019-09-30 Source
Capital expenditure: 229000 USD · 2019-01-01 – 2019-06-30 Source
Capital expenditure: 455000 USD · 2019-01-01 – 2019-12-31 Source
Capital expenditure: 337000 USD · 2019-01-01 – 2019-09-30 Source
Capital expenditure: 100000 USD · 2020-01-01 – 2020-03-31 Source
Capital expenditure: 103000 USD · 2020-01-01 – 2020-06-30 Source
Capital expenditure: 100000 USD · 2020-01-01 – 2020-03-31 Source

Free cash flow

-40.8 million USD

2019-07-01 – 2020-06-30

Exact inputs and evidence

Operating cash flow: -24463000 USD · 2019-01-01 – 2019-09-30 Source
Operating cash flow: -20450000 USD · 2019-01-01 – 2019-06-30 Source
Operating cash flow: -29570000 USD · 2019-01-01 – 2019-12-31 Source
Operating cash flow: -24463000 USD · 2019-01-01 – 2019-09-30 Source
Operating cash flow: -9322000 USD · 2020-01-01 – 2020-03-31 Source
Operating cash flow: -31322000 USD · 2020-01-01 – 2020-06-30 Source
Operating cash flow: -9322000 USD · 2020-01-01 – 2020-03-31 Source
Capital expenditure: 337000 USD · 2019-01-01 – 2019-09-30 Source
Capital expenditure: 229000 USD · 2019-01-01 – 2019-06-30 Source
Capital expenditure: 455000 USD · 2019-01-01 – 2019-12-31 Source
Capital expenditure: 337000 USD · 2019-01-01 – 2019-09-30 Source
Capital expenditure: 100000 USD · 2020-01-01 – 2020-03-31 Source
Capital expenditure: 103000 USD · 2020-01-01 – 2020-06-30 Source
Capital expenditure: 100000 USD · 2020-01-01 – 2020-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2020-08-14.

Financial data available through: 2019-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2019-12-31
Operating income: 11 of 11 periods available· newest 2019-12-31
Net income: 11 of 11 periods available· newest 2019-12-31
Operating cash flow: 11 of 11 periods available· newest 2019-12-31
Capital expenditure: 11 of 11 periods available· newest 2019-12-31
Total assets: 6 of 11 periods available· newest 2019-12-31
Total liabilities: 6 of 11 periods available· newest 2019-12-31
Current assets: 6 of 11 periods available· newest 2019-12-31
Current liabilities: 6 of 11 periods available· newest 2019-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2019-12-31
Long-term debt including current maturities: 3 of 11 periods available· newest 2019-12-31
Shares outstanding: 5 of 11 periods available· newest 2019-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-8.4%

Prior period

USD 156.47 million

2018-01-01 – 2018-12-31
Current period

USD 143.37 million

2019-01-01 – 2019-12-31

Exact inputs and evidence

143370000 − 156473000 = -13103000 USD

156473000 USD · 2018-01-01 – 2018-12-31
Inspect prior input Prior source
143370000 USD · 2019-01-01 – 2019-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ENDOLOGIX INC /DE/ · 2019-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Year-over-year change in Revenue: -13103000 USD Concept: fundies:Revenue Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 143370000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360620000026/elgx-20191231.xml#456603 Filing: 000101360620000026 Input fundies:Revenue: 156473000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360620000026/elgx-20191231.xml#452807 Filing: 000101360620000026
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 14.96 million

Prior period

−USD 79.71 million

2018-01-01 – 2018-12-31
Current period

−USD 64.76 million

2019-01-01 – 2019-12-31

Exact inputs and evidence

-64757000 − -79714000 = 14957000 USD

-79714000 USD · 2018-01-01 – 2018-12-31
Inspect prior input Prior source
-64757000 USD · 2019-01-01 – 2019-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ENDOLOGIX INC /DE/ · 2019-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Year-over-year change in Net income: 14957000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -64757000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360620000026/elgx-20191231.xml#415315 Filing: 000101360620000026 Input fundies:NetIncome: -79714000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360620000026/elgx-20191231.xml#414324 Filing: 000101360620000026
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 9.04 million

Prior period

−USD 38.61 million

2018-01-01 – 2018-12-31
Current period

−USD 29.57 million

2019-01-01 – 2019-12-31

Exact inputs and evidence

-29570000 − -38613000 = 9043000 USD

-38613000 USD · 2018-01-01 – 2018-12-31
Inspect prior input Prior source
-29570000 USD · 2019-01-01 – 2019-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ENDOLOGIX INC /DE/ · 2019-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Year-over-year change in Operating cash flow: 9043000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -29570000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360620000026/elgx-20191231.xml#413119 Filing: 000101360620000026 Input fundies:OperatingCashFlow: -38613000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360620000026/elgx-20191231.xml#412907 Filing: 000101360620000026
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-24.4%

Prior period

USD 602,000

2018-01-01 – 2018-12-31
Current period

USD 455,000

2019-01-01 – 2019-12-31

Exact inputs and evidence

455000 − 602000 = -147000 USD

602000 USD · 2018-01-01 – 2018-12-31
Inspect prior input Prior source
455000 USD · 2019-01-01 – 2019-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ENDOLOGIX INC /DE/ · 2019-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Year-over-year change in Capital expenditure: -147000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 455000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360620000026/elgx-20191231.xml#432732 Filing: 000101360620000026 Input fundies:CapitalExpenditure: 602000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360620000026/elgx-20191231.xml#432523 Filing: 000101360620000026
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2019 2019-01-01 – 2019-12-31

Revenue USD 143.37 million 100% of revenue
Cost of revenue USD 52.28 million 36% of revenue
Operating expenses USD 133.64 million 93% of revenue
Operating income −USD 42.55 million −30% of revenue
Tax, interest and other Derived USD 22.21 million 15% of revenue
Net income −USD 64.76 million −45% of revenue

Cash

Operating cash flow −USD 29.57 million −21% of revenue
Capital expenditure USD 455,000 0.3% of revenue
Free cash flow Derived −USD 30.03 million −21% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2010 Operating loss: operating costs were 106% of revenue.
2016 Operating loss: operating costs were 149% of revenue.
2017 Operating loss: operating costs were 123% of revenue.
2018 Operating loss: operating costs were 144% of revenue.
2019 Operating loss: operating costs were 130% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2010 2010-01-01 – 2010-12-31	67251000	71475000 Derived	-4224000	-14877000 Derived	10653000	-4974000 Derived	Source 2010-01-01 – 2010-12-31: 67251000 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -4224000 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: 10653000 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -4113000 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 861000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	192925000	287999000 Derived	-95074000	59603000 Derived	-154677000	-75603000 Derived	Source 2016-01-01 – 2016-12-31: 192925000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -95074000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -154677000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -72807000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 2796000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	181157000	222977000 Derived	-41820000	24580000 Derived	-66400000	-36573000 Derived	Source 2017-01-01 – 2017-12-31: 181157000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -41820000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -66400000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -35403000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 1170000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	156473000	224665000 Derived	-68192000	11522000 Derived	-79714000	-39215000 Derived	Source 2018-01-01 – 2018-12-31: 156473000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -68192000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -79714000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -38613000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 602000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	143370000	185919000 Derived	-42549000	22208000 Derived	-64757000	-30025000 Derived	Source 2019-01-01 – 2019-12-31: 143370000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -42549000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -64757000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -29570000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 455000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 143.4M 2019

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-12-31	Revenue	52441000	Revenue: 52441000 Open source
20102010-12-31	Revenue	67251000	Revenue: 67251000 Open source
20162016-12-31	Revenue	192925000	Revenue: 192925000 Open source
20172017-12-31	Revenue	181157000	Revenue: 181157000 Open source
20182018-12-31	Revenue	156473000	Revenue: 156473000 Open source
20192019-12-31	Revenue	143370000	Revenue: 143370000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-8.4% 2019

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Year over year	No prior comparable period	Revenue: 52441000 Open source
20102010-12-31	Year over year	28.2%	Revenue: 67251000 Open source Revenue: 52441000 Open source
20162016-12-31	Year over year	No prior comparable period	Revenue: 192925000 Open source
20172017-12-31	Year over year	-6.1%	Revenue: 181157000 Open source Revenue: 192925000 Open source
20182018-12-31	Year over year	-13.6%	Revenue: 156473000 Open source Revenue: 181157000 Open source
20192019-12-31	Year over year	-8.4%	Revenue: 143370000 Open source Revenue: 156473000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -29.7% 2019

Net margin -45.2% 2019

Free cash flow margin -20.9% 2019

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Operating margin	-4.5%	Operating Income: -2342000 Open source Revenue: 52441000 Open source
20102010-12-31	Operating margin	-6.3%	Operating Income: -4224000 Open source Revenue: 67251000 Open source
20162016-12-31	Operating margin	-49.3%	Operating Income: -95074000 Open source Revenue: 192925000 Open source
20172017-12-31	Operating margin	-23.1%	Operating Income: -41820000 Open source Revenue: 181157000 Open source
20182018-12-31	Operating margin	-43.6%	Operating Income: -68192000 Open source Revenue: 156473000 Open source
20192019-12-31	Operating margin	-29.7%	Operating Income: -42549000 Open source Revenue: 143370000 Open source
20092009-12-31	Net margin	20.3%	Net Income: 10653000 Open source Revenue: 52441000 Open source
20102010-12-31	Net margin	15.8%	Net Income: 10653000 Open source Revenue: 67251000 Open source
20162016-12-31	Net margin	-80.2%	Net Income: -154677000 Open source Revenue: 192925000 Open source
20172017-12-31	Net margin	-36.7%	Net Income: -66400000 Open source Revenue: 181157000 Open source
20182018-12-31	Net margin	-50.9%	Net Income: -79714000 Open source Revenue: 156473000 Open source
20192019-12-31	Net margin	-45.2%	Net Income: -64757000 Open source Revenue: 143370000 Open source
20092009-12-31	Free cash flow margin	Not reported	Revenue: 52441000 Open source
20102010-12-31	Free cash flow margin	-7.4%	Revenue: 67251000 Open source Operating Cash Flow: -4113000 Open source Capital Expenditure: 861000 Open source
20162016-12-31	Free cash flow margin	-39.2%	Revenue: 192925000 Open source Operating Cash Flow: -72807000 Open source Capital Expenditure: 2796000 Open source
20172017-12-31	Free cash flow margin	-20.2%	Revenue: 181157000 Open source Operating Cash Flow: -35403000 Open source Capital Expenditure: 1170000 Open source
20182018-12-31	Free cash flow margin	-25.1%	Revenue: 156473000 Open source Operating Cash Flow: -38613000 Open source Capital Expenditure: 602000 Open source
20192019-12-31	Free cash flow margin	-20.9%	Revenue: 143370000 Open source Operating Cash Flow: -29570000 Open source Capital Expenditure: 455000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -29.6M 2019

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-12-31	Operating cash flow	Not reported	No source recorded
20102010-12-31	Operating cash flow	-4113000	Operating Cash Flow: -4113000 Open source
20162016-12-31	Operating cash flow	-72807000	Operating Cash Flow: -72807000 Open source
20172017-12-31	Operating cash flow	-35403000	Operating Cash Flow: -35403000 Open source
20182018-12-31	Operating cash flow	-38613000	Operating Cash Flow: -38613000 Open source
20192019-12-31	Operating cash flow	-29570000	Operating Cash Flow: -29570000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -30M 2019

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-12-31	Free cash flow	Unavailable	No source recorded
20102010-12-31	Free cash flow	-4974000	Operating Cash Flow: -4113000 Open source Capital Expenditure: 861000 Open source
20162016-12-31	Free cash flow	-75603000	Operating Cash Flow: -72807000 Open source Capital Expenditure: 2796000 Open source
20172017-12-31	Free cash flow	-36573000	Operating Cash Flow: -35403000 Open source Capital Expenditure: 1170000 Open source
20182018-12-31	Free cash flow	-39215000	Operating Cash Flow: -38613000 Open source Capital Expenditure: 602000 Open source
20192019-12-31	Free cash flow	-30025000	Operating Cash Flow: -29570000 Open source Capital Expenditure: 455000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

79.2% 2019

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Liabilities / assets	16.4%	Total Liabilities: 8412000 Open source Total Assets: 51292000 Open source
20102010-12-31	Liabilities / assets	30.1%	Total Liabilities: 40472000 Open source Total Assets: 134375000 Open source
20162016-12-31	Liabilities / assets	68.6%	Total Liabilities: 246891000 Open source Total Assets: 359684000 Open source
20172017-12-31	Liabilities / assets	79.4%	Total Liabilities: 289985000 Open source Total Assets: 365047000 Open source
20182018-12-31	Liabilities / assets	86.5%	Total Liabilities: 253424000 Open source Total Assets: 293070000 Open source
20192019-12-31	Liabilities / assets	79.2%	Total Liabilities: 243308000 Open source Total Assets: 307164000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.68× 2019

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Current assets / current liabilities	5.27×	Current Assets: 38339000 Open source Current Liabilities: 7278000 Open source
20102010-12-31	Current assets / current liabilities	5.32×	Current Assets: 59828000 Open source Current Liabilities: 11243000 Open source
20162016-12-31	Current assets / current liabilities	2.89×	Current Assets: 129845000 Open source Current Liabilities: 44902000 Open source
20172017-12-31	Current assets / current liabilities	2.36×	Current Assets: 143134000 Open source Current Liabilities: 60630000 Open source
20182018-12-31	Current assets / current liabilities	2.03×	Current Assets: 78931000 Open source Current Liabilities: 38927000 Open source
20192019-12-31	Current assets / current liabilities	1.68×	Current Assets: 93703000 Open source Current Liabilities: 55793000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2010 2010-01-01 – 2010-12-31	USD 10.65 million Exact value Exact value: 10653000 USD 2010-01-01 – 2010-12-31: 10653000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENDOLOGIX INC /DE/ · 2010-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Net Income: 10653000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: 10653000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360613000019/elgx-20121231.xml#806220 Filing: 000101360613000019 The citation records this snapshot. The page link may show a newer release later.	−USD 4.11 million Exact value Exact value: -4113000 USD 2010-01-01 – 2010-12-31: -4113000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENDOLOGIX INC /DE/ · 2010-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Operating Cash Flow: -4113000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4113000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360613000019/elgx-20121231.xml#805704 Filing: 000101360613000019 The citation records this snapshot. The page link may show a newer release later.	USD 861,000 Exact value Exact value: 861000 USD 2010-01-01 – 2010-12-31: 861000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ENDOLOGIX INC /DE/ · 2010-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Capital Expenditure: 861000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 861000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360613000019/elgx-20121231.xml#823905 Filing: 000101360613000019 The citation records this snapshot. The page link may show a newer release later.	−USD 4.97 million Calculation and evidence -4113000 − 861000 USD Exact free cash flow: -4974000 USD 2010-01-01 – 2010-12-31: -4113000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 861000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ENDOLOGIX INC /DE/ · 2010-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Free cash flow: -4974000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4113000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360613000019/elgx-20121231.xml#805704 Filing: 000101360613000019 Input fundies:CapitalExpenditure: 861000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360613000019/elgx-20121231.xml#823905 Filing: 000101360613000019 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 28.73 million Exact value Exact value: -28730000 USD 2011-01-01 – 2011-12-31: -28730000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENDOLOGIX INC /DE/ · 2011-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Net Income: -28730000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -28730000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360614000012/elgx-20131231.xml#738512 Filing: 000101360614000012 The citation records this snapshot. The page link may show a newer release later.	−USD 22.38 million Exact value Exact value: -22382000 USD 2011-01-01 – 2011-12-31: -22382000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENDOLOGIX INC /DE/ · 2011-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Operating Cash Flow: -22382000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22382000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360614000012/elgx-20131231.xml#738145 Filing: 000101360614000012 The citation records this snapshot. The page link may show a newer release later.	USD 3.03 million Exact value Exact value: 3033000 USD 2011-01-01 – 2011-12-31: 3033000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ENDOLOGIX INC /DE/ · 2011-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Capital Expenditure: 3033000 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3033000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360614000012/elgx-20131231.xml#757818 Filing: 000101360614000012 The citation records this snapshot. The page link may show a newer release later.	−USD 25.42 million Calculation and evidence -22382000 − 3033000 USD Exact free cash flow: -25415000 USD 2011-01-01 – 2011-12-31: -22382000 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 3033000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ENDOLOGIX INC /DE/ · 2011-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Free cash flow: -25415000 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -22382000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360614000012/elgx-20131231.xml#738145 Filing: 000101360614000012 Input fundies:CapitalExpenditure: 3033000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360614000012/elgx-20131231.xml#757818 Filing: 000101360614000012 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 35.77 million Exact value Exact value: -35774000 USD 2012-01-01 – 2012-12-31: -35774000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENDOLOGIX INC /DE/ · 2012-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Net Income: -35774000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -35774000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360615000016/elgx-20141231.xml#342735 Filing: 000101360615000016 The citation records this snapshot. The page link may show a newer release later.	−USD 18.53 million Exact value Exact value: -18529000 USD 2012-01-01 – 2012-12-31: -18529000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENDOLOGIX INC /DE/ · 2012-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Operating Cash Flow: -18529000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18529000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360615000016/elgx-20141231.xml#342101 Filing: 000101360615000016 The citation records this snapshot. The page link may show a newer release later.	USD 2.24 million Exact value Exact value: 2238000 USD 2012-01-01 – 2012-12-31: 2238000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ENDOLOGIX INC /DE/ · 2012-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Capital Expenditure: 2238000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2238000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360615000016/elgx-20141231.xml#357355 Filing: 000101360615000016 The citation records this snapshot. The page link may show a newer release later.	−USD 20.77 million Calculation and evidence -18529000 − 2238000 USD Exact free cash flow: -20767000 USD 2012-01-01 – 2012-12-31: -18529000 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 2238000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ENDOLOGIX INC /DE/ · 2012-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Free cash flow: -20767000 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18529000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360615000016/elgx-20141231.xml#342101 Filing: 000101360615000016 Input fundies:CapitalExpenditure: 2238000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360615000016/elgx-20141231.xml#357355 Filing: 000101360615000016 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 16.07 million Exact value Exact value: -16068000 USD 2013-01-01 – 2013-12-31: -16068000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENDOLOGIX INC /DE/ · 2013-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Net Income: -16068000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16068000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360616000208/elgx-20151231.xml#337250 Filing: 000101360616000208 The citation records this snapshot. The page link may show a newer release later.	USD 1.49 million Exact value Exact value: 1494000 USD 2013-01-01 – 2013-12-31: 1494000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENDOLOGIX INC /DE/ · 2013-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Operating Cash Flow: 1494000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1494000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360616000208/elgx-20151231.xml#336616 Filing: 000101360616000208 The citation records this snapshot. The page link may show a newer release later.	USD 2.86 million Exact value Exact value: 2862000 USD 2013-01-01 – 2013-12-31: 2862000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ENDOLOGIX INC /DE/ · 2013-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Capital Expenditure: 2862000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2862000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360616000208/elgx-20151231.xml#352780 Filing: 000101360616000208 The citation records this snapshot. The page link may show a newer release later.	−USD 1.37 million Calculation and evidence 1494000 − 2862000 USD Exact free cash flow: -1368000 USD 2013-01-01 – 2013-12-31: 1494000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 2862000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ENDOLOGIX INC /DE/ · 2013-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Free cash flow: -1368000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1494000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360616000208/elgx-20151231.xml#336616 Filing: 000101360616000208 Input fundies:CapitalExpenditure: 2862000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360616000208/elgx-20151231.xml#352780 Filing: 000101360616000208 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 32.42 million Exact value Exact value: -32418000 USD 2014-01-01 – 2014-12-31: -32418000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENDOLOGIX INC /DE/ · 2014-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Net Income: -32418000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -32418000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360617000032/elgx-20161231.xml#358408 Filing: 000101360617000032 The citation records this snapshot. The page link may show a newer release later.	−USD 26.33 million Exact value Exact value: -26334000 USD 2014-01-01 – 2014-12-31: -26334000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENDOLOGIX INC /DE/ · 2014-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Operating Cash Flow: -26334000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -26334000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360617000032/elgx-20161231.xml#357772 Filing: 000101360617000032 The citation records this snapshot. The page link may show a newer release later.	USD 13.46 million Exact value Exact value: 13461000 USD 2014-01-01 – 2014-12-31: 13461000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ENDOLOGIX INC /DE/ · 2014-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Capital Expenditure: 13461000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13461000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360617000032/elgx-20161231.xml#374961 Filing: 000101360617000032 The citation records this snapshot. The page link may show a newer release later.	−USD 39.8 million Calculation and evidence -26334000 − 13461000 USD Exact free cash flow: -39795000 USD 2014-01-01 – 2014-12-31: -26334000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 13461000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ENDOLOGIX INC /DE/ · 2014-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Free cash flow: -39795000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -26334000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360617000032/elgx-20161231.xml#357772 Filing: 000101360617000032 Input fundies:CapitalExpenditure: 13461000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360617000032/elgx-20161231.xml#374961 Filing: 000101360617000032 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 50.42 million Exact value Exact value: -50424000 USD 2015-01-01 – 2015-12-31: -50424000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENDOLOGIX INC /DE/ · 2015-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Net Income: -50424000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -50424000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360618000025/elgx-20171231.xml#356451 Filing: 000101360618000025 The citation records this snapshot. The page link may show a newer release later.	−USD 31.09 million Exact value Exact value: -31092000 USD 2015-01-01 – 2015-12-31: -31092000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENDOLOGIX INC /DE/ · 2015-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Operating Cash Flow: -31092000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31092000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360618000025/elgx-20171231.xml#355815 Filing: 000101360618000025 The citation records this snapshot. The page link may show a newer release later.	USD 4.19 million Exact value Exact value: 4191000 USD 2015-01-01 – 2015-12-31: 4191000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ENDOLOGIX INC /DE/ · 2015-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Capital Expenditure: 4191000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4191000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360618000025/elgx-20171231.xml#371693 Filing: 000101360618000025 The citation records this snapshot. The page link may show a newer release later.	−USD 35.28 million Calculation and evidence -31092000 − 4191000 USD Exact free cash flow: -35283000 USD 2015-01-01 – 2015-12-31: -31092000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 4191000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ENDOLOGIX INC /DE/ · 2015-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Free cash flow: -35283000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -31092000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360618000025/elgx-20171231.xml#355815 Filing: 000101360618000025 Input fundies:CapitalExpenditure: 4191000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360618000025/elgx-20171231.xml#371693 Filing: 000101360618000025 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 154.68 million Exact value Exact value: -154677000 USD 2016-01-01 – 2016-12-31: -154677000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENDOLOGIX INC /DE/ · 2016-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Net Income: -154677000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -154677000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360619000059/elgx-20181231.xml#404109 Filing: 000101360619000059 The citation records this snapshot. The page link may show a newer release later.	−USD 72.81 million Exact value Exact value: -72807000 USD 2016-01-01 – 2016-12-31: -72807000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENDOLOGIX INC /DE/ · 2016-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Operating Cash Flow: -72807000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -72807000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360619000059/elgx-20181231.xml#403473 Filing: 000101360619000059 The citation records this snapshot. The page link may show a newer release later.	USD 2.8 million Exact value Exact value: 2796000 USD 2016-01-01 – 2016-12-31: 2796000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ENDOLOGIX INC /DE/ · 2016-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Capital Expenditure: 2796000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2796000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360619000059/elgx-20181231.xml#423904 Filing: 000101360619000059 The citation records this snapshot. The page link may show a newer release later.	−USD 75.6 million Calculation and evidence -72807000 − 2796000 USD Exact free cash flow: -75603000 USD 2016-01-01 – 2016-12-31: -72807000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 2796000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ENDOLOGIX INC /DE/ · 2016-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Free cash flow: -75603000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -72807000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360619000059/elgx-20181231.xml#403473 Filing: 000101360619000059 Input fundies:CapitalExpenditure: 2796000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360619000059/elgx-20181231.xml#423904 Filing: 000101360619000059 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 66.4 million Exact value Exact value: -66400000 USD 2017-01-01 – 2017-12-31: -66400000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENDOLOGIX INC /DE/ · 2017-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Net Income: -66400000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -66400000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360620000026/elgx-20191231.xml#413331 Filing: 000101360620000026 The citation records this snapshot. The page link may show a newer release later.	−USD 35.4 million Exact value Exact value: -35403000 USD 2017-01-01 – 2017-12-31: -35403000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENDOLOGIX INC /DE/ · 2017-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Operating Cash Flow: -35403000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -35403000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360620000026/elgx-20191231.xml#412695 Filing: 000101360620000026 The citation records this snapshot. The page link may show a newer release later.	USD 1.17 million Exact value Exact value: 1170000 USD 2017-01-01 – 2017-12-31: 1170000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ENDOLOGIX INC /DE/ · 2017-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Capital Expenditure: 1170000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1170000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360620000026/elgx-20191231.xml#432313 Filing: 000101360620000026 The citation records this snapshot. The page link may show a newer release later.	−USD 36.57 million Calculation and evidence -35403000 − 1170000 USD Exact free cash flow: -36573000 USD 2017-01-01 – 2017-12-31: -35403000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 1170000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ENDOLOGIX INC /DE/ · 2017-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Free cash flow: -36573000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -35403000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360620000026/elgx-20191231.xml#412695 Filing: 000101360620000026 Input fundies:CapitalExpenditure: 1170000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360620000026/elgx-20191231.xml#432313 Filing: 000101360620000026 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 79.71 million Exact value Exact value: -79714000 USD 2018-01-01 – 2018-12-31: -79714000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENDOLOGIX INC /DE/ · 2018-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Net Income: -79714000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -79714000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360620000026/elgx-20191231.xml#414324 Filing: 000101360620000026 The citation records this snapshot. The page link may show a newer release later.	−USD 38.61 million Exact value Exact value: -38613000 USD 2018-01-01 – 2018-12-31: -38613000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENDOLOGIX INC /DE/ · 2018-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Operating Cash Flow: -38613000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -38613000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360620000026/elgx-20191231.xml#412907 Filing: 000101360620000026 The citation records this snapshot. The page link may show a newer release later.	USD 602,000 Exact value Exact value: 602000 USD 2018-01-01 – 2018-12-31: 602000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ENDOLOGIX INC /DE/ · 2018-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Capital Expenditure: 602000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 602000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360620000026/elgx-20191231.xml#432523 Filing: 000101360620000026 The citation records this snapshot. The page link may show a newer release later.	−USD 39.22 million Calculation and evidence -38613000 − 602000 USD Exact free cash flow: -39215000 USD 2018-01-01 – 2018-12-31: -38613000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 602000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ENDOLOGIX INC /DE/ · 2018-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Free cash flow: -39215000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -38613000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360620000026/elgx-20191231.xml#412907 Filing: 000101360620000026 Input fundies:CapitalExpenditure: 602000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360620000026/elgx-20191231.xml#432523 Filing: 000101360620000026 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 64.76 million Exact value Exact value: -64757000 USD 2019-01-01 – 2019-12-31: -64757000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENDOLOGIX INC /DE/ · 2019-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Net Income: -64757000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -64757000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360620000026/elgx-20191231.xml#415315 Filing: 000101360620000026 The citation records this snapshot. The page link may show a newer release later.	−USD 29.57 million Exact value Exact value: -29570000 USD 2019-01-01 – 2019-12-31: -29570000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENDOLOGIX INC /DE/ · 2019-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Operating Cash Flow: -29570000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -29570000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360620000026/elgx-20191231.xml#413119 Filing: 000101360620000026 The citation records this snapshot. The page link may show a newer release later.	USD 455,000 Exact value Exact value: 455000 USD 2019-01-01 – 2019-12-31: 455000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ENDOLOGIX INC /DE/ · 2019-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Capital Expenditure: 455000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 455000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360620000026/elgx-20191231.xml#432732 Filing: 000101360620000026 The citation records this snapshot. The page link may show a newer release later.	−USD 30.03 million Calculation and evidence -29570000 − 455000 USD Exact free cash flow: -30025000 USD 2019-01-01 – 2019-12-31: -29570000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 455000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ENDOLOGIX INC /DE/ · 2019-12-31 ENDOLOGIX INC /DE/ (edgar:1013606) Free cash flow: -30025000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013606?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -29570000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360620000026/elgx-20191231.xml#413119 Filing: 000101360620000026 Input fundies:CapitalExpenditure: 455000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013606/000101360620000026/elgx-20191231.xml#432732 Filing: 000101360620000026 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

119 filings · 3,265 latest values · 3,265 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001013606, 1013606, edgar:1013606

Also known as CARDIOVASCULAR DYNAMICS INC, ENDOLOGIX INC /DE/, RADIANCE MEDICAL SYSTEMS INC /DE/

ENDOLOGIX INC /DE/

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2019 2019-01-01 – 2019-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation